Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Surgery Partners (SGRY) Accumulated Depreciation & Amortization (2016 - 2025)

Surgery Partners (SGRY) has disclosed Accumulated Depreciation & Amortization for 13 consecutive years, with $176.0 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 15.33% to $176.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $176.0 million through Dec 2025, up 15.33% year-over-year, with the annual reading at $176.0 million for FY2025, 15.33% up from the prior year.
  • Accumulated Depreciation & Amortization hit $176.0 million in Q4 2025 for Surgery Partners, up from $116.1 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $272.3 million in Q4 2021 to a low of $25.2 million in Q2 2021.
  • Historically, Accumulated Depreciation & Amortization has averaged $94.8 million across 5 years, with a median of $76.6 million in 2025.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: crashed 57.84% in 2022 and later soared 131.27% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $272.3 million in 2021, then plummeted by 57.84% to $114.8 million in 2022, then increased by 2.87% to $118.1 million in 2023, then rose by 29.21% to $152.6 million in 2024, then rose by 15.33% to $176.0 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for SGRY at $176.0 million in Q4 2025, $116.1 million in Q3 2025, and $76.6 million in Q2 2025.